Trypanosoma cruzi immunosuppressive factor decreases the interleukin-2 mRNA level in cultured normal activated human

S Majumder1, F Kierszenbaum

  • 1Department of Microbiology, Michigan State University, East Lansing 48824, USA.

Infection and Immunity
|November 1, 1995
PubMed

Insights

Trypanosoma cruzi infection inhibits interleukin-2 production by affecting human immune cells. This study identifies a specific filtrate from T. cruzi that reproduces this inhibition in vitro, offering insights into parasite-induced immune dysfunction.

Area of Science:

  • Immunology
  • Parasitology
  • Molecular Biology

Background:

  • Acutely infected hosts with Trypanosoma cruzi exhibit significant inhibition of interleukin-2 (IL-2) production.
  • Understanding the mechanisms behind this immune suppression is crucial for addressing Chagas disease pathology.

Purpose of the Study:

  • To investigate the in vitro effects of Trypanosoma cruzi on interleukin-2 production in human peripheral blood mononuclear cells (PBMCs).
  • To determine if T. cruzi components can directly inhibit IL-2 synthesis and to explore the underlying molecular mechanisms.

Main Methods:

  • Culturing activated human peripheral blood mononuclear cells (PBMCs) with a suspension filtrate from Trypanosoma cruzi.
  • Analyzing interleukin-2 (IL-2) mRNA levels and other relevant mRNA molecules to assess the impact on lymphocyte activation.

Main Results:

  • A T. cruzi suspension filtrate markedly inhibited interleukin-2 production in activated human PBMCs.
  • This inhibition was not attributed to accelerated IL-2 mRNA decay and appeared selective, as other activation-related mRNA levels remained largely unaffected.

Conclusions:

  • Trypanosoma cruzi possesses components that can directly suppress interleukin-2 production in human immune cells in vitro.
  • This in vitro system using normal lymphoid cells provides a model to study T. cruzi-induced lymphocyte dysfunction mechanisms relevant to infected hosts.